Two stage open label followed by placebo controlled Phase 2 study of Pracinostat and Azicitidine in paitents with IPSS-R High and Very High Risk MDS untreated with HMA’s

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Two stage open label followed by placebo controlled Phase 2 study of Pracinostat and Azicitidine in paitents with IPSS-R High and Very High Risk MDS untreated with HMA’s

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.